• AFP-Jiji

  • SHARE

A Japanese biotechnology startup said Tuesday that it has successfully identified patients with pancreatic cancer using genetically modified roundworms.

Tokyo-based Hirotsu Bio Science Inc. hopes to commercialize a simple test with the technology using a drop of urine for pancreatic cancer — which is difficult to spot at an early stage — within the next year.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)